Related Experiment Video
Updated: Dec 14, 2025
Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
Published on: August 13, 2013
MiR-669b-3p regulates CD4+ T cell function by down-regulating indoleamine-2, 3-dioxygenase
Chuan Li1, Xi Wang1, Fang Yuan1
1Department of General Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China.
Objective:
Acute rejection is a major cause of morbidity and mortality after solid organ transplantation. Therefore, optimizing treatment strategies and improving curative effect is urgent and necessary. Reliable biomarkers for acute rejection and the underlying molecular mechanisms remain to be determined.
Methods:
In this study, we established a mouse-to-mouse cardiac transplantation model and identified miR-669b-3p as a potential biomarker of acute rejection using a microRNA polymerase chain reaction (PCR)-based chip assay.
Results:
Further analyses showed that miR-669b-3p negatively regulated indoleamine-2,3-dioxygenase (IDO), a rate-limiting enzyme of tryptophan catabolism inhibiting T cell function. Using mixed lymphocyte reaction assay, we showed that miR-669b-3p increased proliferation stimulation index and inhibited apoptosis in CD4+ T cells. Moreover, miR-669b-3p regulated the expression of inflammatory cytokines such as tumor necrosis factor alpha (TNF-α) and Interleukin 10 (IL-10) and contributed to cytokine shift towards a Th2-dominant response.
Conclusion:
Our results advance the current understanding of the immune regulatory function of miRNA and shed light on the role of miR-669b-3p in CD4+ T cells, suggesting that miR-669b-3p is a potential target for acute allograft rejection.
Insights
Researchers identified miR-669b-3p as a potential biomarker for acute rejection after organ transplantation. This microRNA influences T cell function and inflammatory responses, offering a new therapeutic target.
Area of Science:
- Immunology
- Molecular Biology
- Transplantation Science
Background:
- Acute rejection remains a significant challenge in solid organ transplantation, leading to morbidity and mortality.
- Identifying reliable biomarkers and understanding molecular mechanisms of acute rejection are crucial for improving outcomes.
Purpose of the Study:
- To identify novel biomarkers for acute rejection.
- To elucidate the molecular mechanisms underlying acute rejection in a transplantation model.
Main Methods:
- Established a mouse-to-mouse cardiac transplantation model.
- Utilized a microRNA polymerase chain reaction (PCR)-based chip assay to identify potential biomarkers.
- Performed mixed lymphocyte reaction assays and analyzed cytokine expression.
Main Results:
- Identified miR-669b-3p as a potential biomarker for acute rejection.
- Demonstrated that miR-669b-3p negatively regulates indoleamine-2,3-dioxygenase (IDO), impacting T cell function.
- Showed miR-669b-3p promotes CD4+ T cell proliferation, inhibits apoptosis, and shifts cytokine profiles towards a Th2 response.
Conclusions:
- miR-669b-3p plays a role in regulating immune responses in CD4+ T cells.
- miR-669b-3p is a potential therapeutic target for managing acute allograft rejection.
Related Concept Videos
01:24T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:24B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
01:22T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
01:15Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...